Edition:
United Kingdom

Citius Pharmaceuticals Inc (CTXR.OQ)

CTXR.OQ on NASDAQ Stock Exchange Capital Market

1.64USD
19 Oct 2018
Change (% chg)

$-0.06 (-3.53%)
Prev Close
$1.70
Open
$1.63
Day's High
$1.65
Day's Low
$1.59
Volume
18,257
Avg. Vol
37,382
52-wk High
$5.46
52-wk Low
$1.12

Chart for

About

Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of critical care products targeting medical needs with a focus on anti-infective products, adjunctive cancer care, and prescription products. Its product candidates include Mino-Lok and Hydrocortiso... (more)

Overall

Beta: --
Market Cap(Mil.): $26.02
Shares Outstanding(Mil.): 8.25
Dividend: --
Yield (%): --

Financials

  CTXR.OQ Industry Sector
P/E (TTM): -- 30.91 33.65
EPS (TTM): -2.01 -- --
ROI: -66.76 14.75 14.28
ROE: -66.76 16.25 16.00

BRIEF-Citius Pharmaceuticals To Sell Up To 1.4 Mln Shares Of Co's Common Stock

* CITIUS PHARMACEUTICALS - TO SELL OR OTHER DISPOSITION FROM TIME TO TIME OF UP TO 1.4 MILLION SHARES OF CO'S COMMON STOCK Source : https://bit.ly/2JdehV7 Further company coverage: (Reuters.Briefs@thomsonreuters.com)

20 Apr 2018

Earnings vs. Estimates